Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Asset disposition
Appointed director
CORCEPT THERAPEUTICS INC (CORT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
02/28/2023 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 AUDITED FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
08/03/2022 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
05/05/2022 8-K Quarterly results
02/15/2022 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2021 AUDITED FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
11/03/2021 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
07/29/2021 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
05/06/2021 8-K Quarterly results
02/23/2021 8-K Quarterly results
11/03/2020 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
08/04/2020 8-K Quarterly results
05/04/2020 8-K Quarterly results
02/20/2020 8-K Quarterly results
11/07/2019 8-K Quarterly results
Docs: "Corcept Therapeutics Announces Third Quarter 2019 Financial Results and Provides Corporate Update MENLO PARK, Calif. - Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, today reported its results for the quarter ended September 30, 2019."
08/01/2019 8-K Quarterly results
Docs: "Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update"
05/09/2019 8-K Quarterly results
Docs: "Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update"
02/25/2019 8-K Quarterly results
11/01/2018 8-K Quarterly results
Docs: "Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update"
08/09/2018 8-K Quarterly results
Docs: "Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update"
05/08/2018 8-K Quarterly results
Docs: "Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update"
02/22/2018 8-K Quarterly results
Docs: "Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial"
11/02/2017 8-K Quarterly results
Docs: "Corcept Therapeutics Announces Third Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update"
05/01/2017 8-K Form 8-K - Current report
03/06/2017 8-K Form 8-K - Current report
11/01/2016 8-K Form 8-K - Current report
08/02/2016 8-K Form 8-K - Current report
05/03/2016 8-K Form 8-K - Current report
03/01/2016 8-K Form 8-K - Current report
11/05/2015 8-K Form 8-K - Current report
08/05/2015 8-K Form 8-K - Current report
05/07/2015 8-K Form 8-K - Current report
03/04/2015 8-K Form 8-K - Current report
11/10/2014 8-K Form 8-K - Current report
08/05/2014 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy